Home / News / India News / Article / Plea in SC seeks action against Ranbaxy

Plea in SC seeks action against Ranbaxy

The Supreme Court was moved Wednesday for a direction to the centre to cancel the manufacturing licences of pharma major Ranbaxy and its group companies for allegedly marketing sub-standard medicines.

  • WhatsAppBookmarkBookmark
Listen to this article :

Petitioner Manohar Lal Sharma, an advocate, sought direction to order closure of Ranbaxy manufacturing units located in Ponta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh and other places under Section 18 the Drugs and Cosmetics Act 1947.

Seeking direction to the Central Bureau of Investigation to initiate a probe into the alleged supply of sub-standard medicines and proceed against all the former and the present directors of Ranbaxy, the public interest litigation sought directions to restrain the drug manufacturing company from marketing its medicines in India.

Read Next Story
Arvind Kejriwal refuses to seek bail in defamation case›

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All